NEW YORK, May 12, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Kimberly-Clark Corporation (NYSE: KMB), Estee Lauder Companies Inc. (NYSE: EL), Nu Skin Enterprises, Inc. (NYSE: NUS), Energizer Holdings Inc. (NYSE: ENR) and Avon Products Inc. (NYSE: AVP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2314-100free.

-- Kimberly-Clark Corporation Analyst Notes On May 6, 2014, Kimberly-Clark Corporation (Kimberly-Clark) announced that its Form 10 Registration Statement, for its previously announced plan to spin off its health care business, has been filed with the SEC. The Company stated that the new Company will be called Halyard Health and it generates approximately $1.7 billion in annual net sales. According to the Company, the spin-off is expected to take the form of a tax-free distribution of 100% Halyard Health's common stock to Kimberly-Clark's shareholders, with the distribution expected to be completed at the end of Q3 2014 or in Q4 2014, subject to market, regulatory and other conditions. According to Kimberly-Clark Chairman and CEO Thomas J. Falk, the spin-off focuses on creating shareholder value and post the spin-off, Halyard Health will be able to take advantage of its leading positions in several key categories thus allowing Kimberly-Clark to focus on growing its consumer and K-C Professional brands around the world. The full analyst notes on Kimberly-Clark are available to download free of charge at:

http://www.analystsreview.com/2314-KMB-12May2014.pdf

-- Estee Lauder Companies Inc. Analyst Notes On May 2, 2014, Estee Lauder Companies Inc. (Estee Lauder) declared a quarterly dividend of $0.20 per share on the Company's Class A and Class B Common Stock. According to the Company, the dividend is payable on June 16, 2014 to stockholders of record at the close of business on May 30, 2014. The full analyst notes on Estee Lauder are available to download free of charge at:

http://www.analystsreview.com/2314-EL-12May2014.pdf

-- Nu Skin Enterprises, Inc. Analyst Notes On May 7, 2014, Nu Skin Enterprises, Inc. (Nu Skin) announced that its Board of Directors has declared a quarterly cash dividend of $0.345 per share. According to the Company, the dividend is payable on June 11, 2014, to stockholders of record on May 23, 2014. The full analyst notes on Nu Skin are available to download free of charge at:

http://www.analystsreview.com/2314-NUS-12May2014.pdf

-- Energizer Holdings Inc. Analyst Notes On April 30, 2014, Energizer Holdings Inc. (Energizer) reported its Q2 FY 2014 financial results (period ended March 31, 2014). Net sales were $1.1 billion, down 3.1% YoY. Net earnings stood at $98.5 million, or $1.57 per diluted share, compared with $84.9 million or $1.35 per diluted share. According to Ward M. Klein, CEO, Energizer Holdings, the Company is continuously making progress with its cost savings initiatives to offset top-line challenges, increased competitive pressures and continued currency headwinds and expects to improve its Personal Care Division thru strong execution of innovation plans and improved category performance. He commented, "Although the top line will remain challenging for Household Products, we believe that continued focus on cost optimization, cash flow generation and sustained investments in support of our brands will help position the business for future success." For full year 2014, Energizer expects net earnings per diluted share of $5.70 to $6.10. The full analyst notes on Energizer are available to download free of charge at:

http://www.analystsreview.com/2314-ENR-12May2014.pdf

-- Avon Products Inc. Analyst Notes On May 1, 2014, Avon Products Inc. (Avon) reported its Q1 2014 financial results. Net sales stood at $2.2 billion, down 11.1% YoY. However, the Company registered quarterly net loss $168.3 million, or $0.38 per diluted share, compared with $13.7 million, or $0.03 per diluted share, in Q1 2013. Sheri McCoy, CEO, Avon, though expressed dissatisfaction with the Company's Q1 financial performance, remains encouraged by the financial progress it is making particularly in Europe, Middle East, and Africa (EMEA). She said, "We continue to stay the course on our plans to return Avon to sustainable, profitable growth." The full analyst notes on Avon Products are available to download free of charge at:

http://www.analystsreview.com/2314-AVP-12May2014.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review